home of the INTERNATIONAL ATHEROSCLEROSIS SOCIETY
  ABOUT IAS  | IAS LEADERSHIP  | MEMBER SOCIETIES  | MEMBERSHIP contact us  | home   

IAS Prevention Guideline plus relevant cardiovascular guidelines from other organizations
Previous and future meetings sponsored by the IAS, the IAS member societies, or relevant affiliated organizations
Current and prior publications that have been sponsored by the IAS, including previous IAS newsletters
Distinguished Fellows of the IAS
Slides available through the IAS, Lorenzini Foundation, and other sites.
IAS monthly newsletter sent by email to all IAS members
Monthly summary of the key literature	in the atherosclerosis field provided each month to all IAS members.
The IAS offers fellowships to young investigators to study in major laboratories
Important websites related to atherosclerosis and related diseases
Computer based algorithms for 10-year risk assessment for cardiovascular disease.
Organizations affiliated with the IAS.


IAS Statin Publication
Update Service


The International Atherosclerosis Society is very pleased to announce an exciting new and informative Newsletter for its membership: The IAS Statin Newsletter. The IAS will begin this month providing curated update on all publications involving statins as identified in PubMed.
For the Issues, click here

ISA 2018 Toronto, Canada

June 9-12, 2018

XVIII International Symposium on
Atherosclerosis
Toronto, Canada


Final Program
Abstract Book
Photos of the Opening Ceremony

Fellowship Awards
Winners 2018


Chiara Macchi
Milan, Italy


Dorothè Maria Kusters
Amsterdam, The Netherlands


Nerea Mendez Barbero
Madrid, Spain


Winner Reports
Winner 2016 - Blake Cochran
Winner 2016 - Ingo Hilgendorf
Winner 2016 - Yosdel Soto
Winner 2015 - Hagit Hochner
Winner 2015 - Kazuyuki Kasahara
Winner 2015 - Wei Tan
Winner 2014 - Amanda Foks
Winner 2014 - Nordin Hanssen
Winner 2014 - Marco Busnelli

last updated: July 6, 2018 

  From the IAS President's Desk

We are thrilled to announce the new Executive Board which will begin its term on January 1, 2019 and will serve until December 31, 2021. The following members were elected during the International Symposium on Atherosclerosis in Toronto, Canada in June, 2018:

  • President Raul Santos (Brazil)
  • President-Elect Peter Libby (USA)
  • Past-President Yuji Matsuzawa (Japan)
  • Secretary Richard Ceska (Czech Republic)
  • Treasurer Jacques Genest (Canada)


  PDAY Study

An Introduction to the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Study
Samuel S. Gidding MD and Richard Vander Heide MD, PhD, MBA

In the mid-1980s, three pioneers of atherosclerosis pathologic research, Robert Wissler MD, Jack Strong MD, and Henry McGill MD initiated the PDAY study. The founding idea was that atherosclerosis developed over the life span of an individual and if the process could be arrested or delayed early in life, the epidemic of acquired cardiovascular disease could be prevented. Essentially, they wanted to build on the observation that atherosclerosis had been identified in the young casualties of the Korean and Viet Nam conflicts by demonstrating the relationship of early atherosclerosis to established risk factors which included elevated serum lipid levels, hypertension, diabetes, smoking, and obesity. The principals all had experience with primate models where all of these risk factors were confirmed to cause atherosclerosis. Read more


  IAS FH Activities

ScreenPro - Screening Project for Familial Hypercholesterolemia in Central, Southern, and Eastern Europe

Severe FH Course “Identifying and Treating Severe Familial Hypercholesterolemia” (Dubai, UAE, October 14-15, 2017)

IAS Consensus Statement “Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel”
The International Atherosclerosis Society (IAS) is proud to announce the publication on the definition of severe FH and the implications for clinical management in The Lancet Diabetes and Endocrinology.

New Data on Familial Hypercholesterolemia in Brazil
For the abstract and full article please click here

E-Learning

News from the Lipid Clinics in Iraq

The SAFEHEART Registry


  New IAS Executive Board (2019-2021)

The IAS Nominating Committee, chaired by Philip Barter (Australia) and composed by Anne Goldberg (USA), Chris Packard (UK), and Brian Tomlinson (Hong Kong), has presented the IAS Council the final slate of the candidates to be elected during the ISA2018 congress in Toronto. The Council of the Constituent Societies has elected the future Board members during its meeting on June 11, 2018.

We are thrilled to announce the new Executive Board which will begin its term on January 1, 2019 and will serve until December 31, 2021. Read more


  New IAS Member Societies

Welcome to our new Member Societies !

Iraqi Lipid Clinics Network

Kuwait 5000

Saudi Group for Cardiovascular Prevention and Rehabilitation


  2018 Antonio M. Gotto, Jr. Prize in Atherosclerosis Research

The Antonio M. Gotto, Jr. Prize in Atherosclerosis Research was awarded to Dr. Daniel J. Rader, an investigator from the Perelman School of Medicine, during the XVIII International Symposium on Atherosclerosis held on June 9-12 in Toronto, Canada.
The triennial Prize, endowed by Weill Cornell Medicine and the International Atherosclerosis Society in honor of Dr. Gotto, Dean Emeritus of Weill Cornell Medicine, recognizes outstanding scientific, medical or organizational advancement in our ability to understand the causes and the development of atherosclerosis.
The award was made in recognition of Daniel’s as a leading translational scientist who has made major contributions to our understanding of lipoprotein metabolism. His work is distinguished by its clear and direct impact on the development of new therapeutic strategies to prevent coronary heart disease (CHD). Rader discovered endothelial lipase and elucidated its role in metabolism of high density lipoproteins (HDL). He developed novel methods to trace macrophage-specific RCT in mice and assess HDL function in humans. Rader also singlehandedly championed microsomal triglyceride transfer protein (MTP) inhibitors for treatment of severe hypercholesterolemia. Rader has provided important new insights into the mechanisms by which common sequence variations discovered in genome-wide association studies alter plasma lipoprotein levels. His work spans the full spectrum of translational research, extending from basic laboratory science to the development and testing of new therapeutic agents in humans. His work has had a major impact on current strategies to prevent and treat CHD.


  XIX International Symposium on Atherosclerosis 2021

Pre-Satellite Symposium (Muscat, Oman, October 19-21, 2021)

ISA2021 Congress (Kyoto, Japan, October 24-27, 2021)


  XX International Atherosclerosis Society 2024 - Winner

We are pleased to announce that after the presentation of the outstanding bids for the ISA2024 Symposium from the Russian National Atherosclerosis Society (RNAS), Emirates Cardiac Society (ECS), Lipid Association of India (LAI), and Oman Society of Lipids & Atherosclerosis (OSLA) the IAS Executive Board during its meeting held in Toronto on June 9 has selected the winner of the ISA2024: the Oman Society of Lipids and Atherosclerosis (OSLA).


  IAS - OSLA Collaboration in the MENA Region

The International Atherosclerosis Society (IAS) and Oman Society of Lipid & Atherosclerosis (OSLA) are organizing the Fifth IAS-OSLA Course "Lipid Metabolism and Cardiovascular Risk" to be held in Muscat, Oman, on February 8-12, 2019.
As in 2015, 2016, 2017 and 2018, the aim of this Course is to increase the knowledge and experience of early- to mid-career, English-speaking practicing clinicians interested in the management of lipid disorders and will be restricted to 30 clinicians from the Middle East and North Africa (MENA) region who manage patients with lipid disorders.

Who can apply: Clinicians (including adult or pediatric cardiologists, endocrinologists, general practitioners, lipidologists, clinical biochemists) below the age of 40 years who are currently working at a hospital/university/other health institute in the MENA region.

More information will follow.


  IAS Commentaries

  Meeting and Educational Activity Highlights
To view all highlights, please click here

  Acknowledgements
The IAS wishes to thank all the supporters which have generously offered grants to the IAS for the development of its many activities and in support of its mission:
Aegerion Pharmaceuticals, Amgen, Inc., Amgen (Europe) GmbH, Amryt, Daiichi Sankyo Co., Ltd., Fondazione Giovanni Lorenzini, OSLA - Oman Society of Lipids and Atherosclerosis, Ono Pharmaceutical Co., Ltd., Otsuka Pharmaceutical Co., Ltd.,Pfizer, Sanofi and Regeneron, and Weill Cornell Medical College


Disclaimer - Cookie policy
This site is optimised for a min. 1024 x 768 pixels resolution

REGISTERED USER
USER ID


PASSWORD




Remember my password


Forgot your password?
Click here


First-time user?
Click here


WHO IS IAS

The International Atherosclerosis Society (IAS), incorporated in 1979, promotes, at an international level, the advancement of science, research and teaching in the field of atherosclerosis and related diseases.

IAS Newsletter Editors & Website Editorial Board

Editor-in-Chief
Scott M. Grundy, MD, PhD
Dallas, TX, USA

Associate Editors
Stefano Bellosta
Milan, Italy

Emanuela Folco
Milan, Italy

Ann Jackson
Houston, TX, USA

Commentary & Newsletter Editor
Yelonda Williams
(Dallas, TX, USA)

Elena Colombo
(Milan, Italy)